Conference abstract · 2017
Conference abstractPublished 5 Dec 2016
Biomarker development for allergic risk assessment
Center for Devices and Radiological Health-US FDA, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
There is an increase in the incidence of allergy/immunotoxicity-related post-market adverse events associated with medical devices. Biomarkers are commonly used in toxicology for risk assessment and clinically as diagnostic and monitoring tests. We developed a new in vitro model where human peripheral blood mononuclear cells (PBMC) serve as immunomodulators for biomarker development specifically for metal related allergenicity. The cell surface proteins were determined quantitatively. One of the purposes is to know whether the biomodulator system is transferable from the dendritic cell (DC) to the PBMC. Out of 12 surface proteins selected from the first tier selection that were screened, we found consistency of BM1 performance between DC and PBMC, and other 3 proteins (BM2, BM3 and BM4) showed promise. The expression of BM1 was down- regulated significantly following exposure to three well-known metallic allergens (Cobalt (II) chloride, nickel (II) sulfate, potassium dichromate (VI)), while the expression remained unchanged when exposed to two metallic nonallergens (lead (IV) acetate, magnesium (II) chloride) compared to untreated cells. Data from four healthy donors showed the same pattern. These results indicate that BM1 shows promise for use as a pre-clinical biomarker in screening potential allergenic risks to metal-containing devices. Further validation is planned.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 19 Oct 2018
Basophil Activation Test as biomarker of allergic desensitization
Conference abstract · 14 Jun 2018
Biomarkers of T cell responses in allergic diseases
Conference abstract
Development of novel biomarkers for allergic diseases
Research article · 30 Dec 2024
An Examination of the Correlation between Advancements in TBI Research and the Long-Term Health Outcomes of High-Risk Populations: The Use of Biomarkers vs. Symptom Assessment
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectImmunology & Microbiology
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Ying Mu”
